RO128701A2 - Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp. - Google Patents

Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp. Download PDF

Info

Publication number
RO128701A2
RO128701A2 ROA201101274A RO201101274A RO128701A2 RO 128701 A2 RO128701 A2 RO 128701A2 RO A201101274 A ROA201101274 A RO A201101274A RO 201101274 A RO201101274 A RO 201101274A RO 128701 A2 RO128701 A2 RO 128701A2
Authority
RO
Romania
Prior art keywords
officinalis
atomized
cynara scolymus
extracts
semi
Prior art date
Application number
ROA201101274A
Other languages
Romanian (ro)
Inventor
Adrian Andrieş
Sultana Niţă
Flavian Ştefan Rădulescu
Dumitru Lupuleasa
Dalia Simona Miron
Svetlana Mihul Colceru
Original Assignee
Universitatea De Medicină Şi Farmacie "Carol Davila" Din Bucureşti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatea De Medicină Şi Farmacie "Carol Davila" Din Bucureşti filed Critical Universitatea De Medicină Şi Farmacie "Carol Davila" Din Bucureşti
Priority to ROA201101274A priority Critical patent/RO128701A2/en
Publication of RO128701A2 publication Critical patent/RO128701A2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a pharmaceutical product intended for topical administration containing 0.01...10% by mass associated atomized extracts of Cynara scolymus, Rosmarinus officinalis and Hyssopus officinalis in a ratio of 40:30:30, 0.5...4% polyacrylate-type lattice forming agent, 1...10% lipophilic absorption promoter, namely polypropylene glycol, triethanol amine, 2...20% ethanol and water for the remainder up to 100%, the percentage being expressed by mass.

Description

Forme farmaceutice semisolide destinate administrării locale, conținând asocieri de extracte atomizate de Cynara scolymus, Rosmarinus officinalis sp. și Hissopus officinalis sp.Semi-solid pharmaceutical forms for local administration, containing combinations of atomized extracts of Cynara scolymus, Rosmarinus officinalis sp. and Hissopus officinalis sp.

Invenția se referă la forme farmaceutice semisolide destinate administrării locale pe piele și mucoase, cu un conținut între 0.1 si 5 % asociere de extracte atomizate de Cynara scolymus, Rosmarinus officinalis sp. și Hissopus officinalis sp..The invention relates to semi-solid pharmaceutical forms for local administration to the skin and mucous membranes, with a content of between 0.1 and 5% combination of atomized extracts of Cynara scolymus, Rosmarinus officinalis sp. and Hissopus officinalis sp ..

Cerererile de brevet de invenție A/011256; 2010 și A/011257; 2010 [Andrieș AA și col] descriu forme farmaceutice semisolide, respectiv solide, conținând extracte atomizate de produse vegetale. Principiile active conținute principii active determină procese de inhibare a acțiunii metaloproteinazelor, generând după administrarea invivo un puternic efect antioxidant. Acesta este corelat cu efecte de combatere a semnelor îmbătrânirii tisulare.Patent applications A / 011256; 2010 and A / 011257; 2010 [Andrieș AA et al] describe semi-solid and solid pharmaceutical forms, containing atomized extracts of plant products. The active principles contained in the active principles determine processes of inhibition of the action of metalloproteinases, generating after the administration of invivo a powerful antioxidant effect. It is correlated with the effects of combating the signs of tissue aging.

Invenția ce face obiectul acestui dosar adaugă complexului de principii active conținutul extractului atomizat de Cynara scolymus, în cadrul unor forme farmaceutice semisolide. Considerând avantajul formelor farmaceutice semisolide hidrofile, precum și variabilitatea caracteristicilor fizico-chimice și prospectiv, a parametrilor biofarmaceutici pentru structurile moleculare care constituie amestecul complex - componente active ale extractelor, s-a urmărit dezvoltarea unor geluri de tip emulsie. Aceste vehicule bifazice prezintă potențialul de a asigura stabilitatea și biodisponibilitatea optimă a ingredientelor active. S-a optat pentru o cantitate minima de alcool etilic și poliol inferior, propilenglicolul. Acest amestec de cosolvenți a fost utilizat pentru dispersarea cantității de complex. Promotorul de absorbție a fost reprezentat fie de izopropil-miristat, fie de combinații ale acestuia cu lanolina și alcoolul oleic, ambele generând forme farmaceutice semisolide de tip emulsie.The invention that is the subject of this file adds to the complex of active principles the content of the atomized extract of Cynara scolymus, in some semi-solid pharmaceutical forms. Considering the advantage of the hydrophilic semi-solid pharmaceutical forms, as well as the variability of the physico-chemical and prospective characteristics, of the biopharmaceutical parameters for the molecular structures that constitute the complex mixture - active components of the extracts, it was followed the development of emulsion type gels. These two-phase vehicles have the potential to ensure optimum stability and bioavailability of active ingredients. The minimum amount of ethyl alcohol and lower polyol, propylene glycol was chosen. This cosolvent mixture was used to disperse the complex amount. The absorption promoter was represented by either isopropyl-myristate or its combinations with lanolin and oleic alcohol, both of which generate semi-solid pharmaceutical forms of emulsion type.

α-2 Ο 1 1 - Ο 1 2 7 4 - - 'Λ ν 2 9 *11' 2011α-2 Ο 1 1 - Ο 1 2 7 4 - - 'Λ ν 2 9 * 11' 2011

Compoziția asocierii de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : Hyssopus officinalis, 40 : 30 : 30 %), utilizate în prepararea formelor farmaceutice semisolide, a fost următoarea:The composition of the atomized powder combination (Cynara scolymus: Rosmarinus officinalis: Hyssopus officinalis, 40: 30: 30%), used in the preparation of the semi-solid pharmaceutical forms, was as follows:

Parametru ConcentrațieConcentration parameter

Acizi polifenolcarboxilici, % (g/g)Polyphenolcarboxylic acids,% (w / w)

-exprimat în acid rozmarinic4.08- expressed in rosmarinic acid4.08

-exprimat în acid cafeic3.18- expressed as caffeic acid 3.18

-exprimat în acid clorogenic3.98- expressed as chlorogenic acid3.98

Flavone, % (g/g)Flavone,% (w / w)

-exprimat în rutin4.56-expressed in routine4.56

Acid rozmarinic, mg/100g 2078.33Rosmarinic acid, mg / 100g 2078.33

Cinarina, mg/100g89.39Cinarine, mg / 100g89.39

Acid clorogenic, mg/100g 246.40Chlorogenic acid, mg / 100g 246.40

Acid cafeic, mg/100g68.34Caffeic acid, mg / 100g68.34

Luteolin 7-glicozida, mg/100g 800.77Luteolin 7-glycoside, mg / 100g 800.77

Apigenin 7-glicozida, mg/100g50.53Apigenin 7-glycoside, mg / 100g50.53

Rutin, mg/100g 305.08Routine, mg / 100g 305.08

Micro și macroelemente, mg/100gMicro and macroelements, mg / 100g

-mangan2.07-mangan2.07

-zinc1.83-zinc1.83

-magneziu-magnesium

807.50807.50

ίί

9 20119 2011

Compoziția generală a formulărilor de tip gel-emulsie este redată în continuare:The general composition of gel-emulsion formulations is shown below:

Component Component Cantitate (g/100g) Quantity (g / 100g) Asociere de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : Association of atomized powders (Cynara scolymus: Rosmarinus officinalis: 0.01 - 10.0 0.01 - 10.0

Hyssopus officinalis, 40:30:30%)Hyssopus officinalis, 40: 30: 30%)

Agent macromolecular poliacrilic Macromolecular polyacrylic agent 0.5-4.0 0.5-4.0 Trietanolamină triethanolamine ad pH 7 at pH 7 Propilenglicol propylene 1.0- 10.0 1.0- 10.0

Promotor de absorbție lipofil de tip izopropil-miristat sau combinați ale acestuia cu acizi grași și alte componente lipidice biocompatibileIsopropyl-myristate-type lipophilic absorption promoter or its combination with fatty acids and other biocompatible lipid components

Etanol absolutAbsolute ethanol

5.0 - 20.05.0 - 20.0

Apa purificată ad 100.0Purified water ad 100.0

Modul de preparareMethod of preparation

Formatorul de rețea de tip poliacrilat (de exemplu carbomer 934, 940) este hidratat, timp de 24 de ore, în 75% din cantitatea de apă prevăzută în formulă. Pentru acest sistem poliacrilic, structurarea gelului s-a realizat prin neutralizare cu trietanol-amina.The polyacrylate network former (for example carbomer 934, 940) is hydrated, for 24 hours, in 75% of the amount of water provided in the formula. For this polyacrylic system, the gel was structured by neutralization with triethanol-amine.

Gelurile rezultate sunt neutralizate, prin adăugare agentului de neutralizare.The resulting gels are neutralized by adding the neutralizing agent.

Asocierea de pulberi atomizate se dizolvă sau se dispersează în amestecul de propilenglicol și etanol, în care a fost dispersat anterior promotorul de absorbție lipofil.The association of atomized powders is dissolved or dispersed in the mixture of propylene glycol and ethanol, in which the lipophilic absorption promoter was previously dispersed.

Gelul neutralizat si sistemul micelar conținând componentele pulberilor din asociere se reunesc și se omogenizează prin agitare lentă.The neutralized gel and the micellar system containing the components of the powders in the association are combined and homogenized by slow agitation.

ÎX-2 Ο 1 1 - Ο 1 2 7 4 - 2 9 -11- 2011ÎX-2 Ο 1 1 - Ο 1 2 7 4 - 2 9 -11- 2011

Exemplul 1 Example 1 Component Component Cantitate (g/100g) Quantity (g / 100g) Asociere de pulberi atomizate (Cynara scolymus ; Rosmarinus officinalis : Hyssopus officinalis, 40:30:30%) Association of atomized powders (Cynara scolymus; Rosmarinus officinalis: Hyssopus officinalis, 40: 30: 30%) 0.5 0.5 Carbomer 940 Carbomer 940 0.5 0.5 Trietanolamină triethanolamine ad pH 7 at pH 7 Propilenglicol propylene 5 5 Izopropil-miristat Isopropyl-myristate 5 5 Etanol absolut Absolute ethanol 10 10

Apa purificată până laPurified water up to

100100

Exemplul 2Example 2

Component Component Cantitate (g/100g) Quantity (g / 100g) Asociere de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : Hyssopus officinalis, 40:30:30%) Association of atomized powders (Cynara scolymus: Rosmarinus officinalis: Hyssopus officinalis, 40: 30: 30%) 0.5 0.5 Carbomer 940 Carbomer 940 0.5 0.5 Trietanolamină triethanolamine ad pH 7 at pH 7 Propilenglicol propylene 5 5 Amestec izopropil-miristat, lanolină și acid oleic Isopropyl-myristate, lanolin and oleic acid mixture 5 5 Etanol absolut Absolute ethanol 10 10 Apa purificată până la Purified water up to 100 100

^- 2 0 1 1 - 0 1 2 7 4-- '7^ - 2 0 1 1 - 0 1 2 7 4-- '7

9 -11- 20119-11-11, 2011

Exemplul 3Example 3

ComponentComponent

Cantitate (g/1OOg)Quantity (g / 1OOg)

Asociere de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : 1Association of atomized powders (Cynara scolymus: Rosmarinus officinalis: 1

Hyssopus officinalis, 40:30:30%)Hyssopus officinalis, 40: 30: 30%)

Carbomer 940Carbomer 940

0.50.5

Trietanolamină ad pH 7Triethanolamine at pH 7

Propilenglicolpropylene

Izopropil-miristatIsopropyl-myristate

Etanol absolutAbsolute ethanol

Apa purificată până laPurified water up to

100100

Exemplul 4Example 4

Component Component Cantitate (g/100g) Quantity (g / 100g) Asociere de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : Hyssopus officinalis, 40:30:30%) Association of atomized powders (Cynara scolymus: Rosmarinus officinalis: Hyssopus officinalis, 40: 30: 30%) 1 1 Carbomer 940 Carbomer 940 0.5 0.5 Trietanolamină triethanolamine ad pH 7 at pH 7 Propilenglicol propylene 5 5 Amestec izopropil-miristat, lanolină și acid oleic Isopropyl-myristate, lanolin and oleic acid mixture 5 5 Etanol absolut Absolute ethanol 10 10

Apa purificată până laPurified water up to

100100

t\- 2 O 1 1 - O 1 2 7 4 - - .7t \ - 2 O 1 1 - O 1 2 7 4 - - .7

9 -11- 20119-11-11, 2011

Exemplul 5Example 5

Component Component Cantitate (g/100g) Quantity (g / 100g) Asociere de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : Association of atomized powders (Cynara scolymus: Rosmarinus officinalis: 0.5 0.5

Hyssopus officinalis, 40:30:30%)Hyssopus officinalis, 40: 30: 30%)

Carbomer 940Carbomer 940

Trietanolamină ad pH 7Triethanolamine at pH 7

Propilenglicolpropylene

Izopropil-miristatIsopropyl-myristate

Etanol absolutAbsolute ethanol

Apa purificată până laPurified water up to

100100

Exemplul 6 Example 6 Component Component Cantitate (g/100g) Quantity (g / 100g) Asociere de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : Hyssopus officinalis, 40:30:30%) Association of atomized powders (Cynara scolymus: Rosmarinus officinalis: Hyssopus officinalis, 40: 30: 30%) 0.5 0.5 Carbomer 940 Carbomer 940 1 1 Trietanolamină triethanolamine ad pH 7 at pH 7 Propilenglicol propylene 5 5 Amestec izopropil-miristat, lanolină și acid oleic Isopropyl-myristate, lanolin and oleic acid mixture 5 5 Etanol absolut Absolute ethanol 10 10

Apa purificată până laPurified water up to

100100

Exemplul 7 (χ- 2 Ο 1 1 - Ο 1 2Example 7 (χ- 2 Ο 1 1 - Ο 1 2

9 -11- 2Π119 -11- 2Π11

Component Component Cantitate (g/100g) Quantity (g / 100g) Asociere de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : Hyssopus officinalis, 40:30:30%) Association of atomized powders (Cynara scolymus: Rosmarinus officinalis: Hyssopus officinalis, 40: 30: 30%) 1 1

Carbomer 940Carbomer 940

Trietanolamină ad pH 7Triethanolamine at pH 7

Propilenglicolpropylene

Izopropil-miristatIsopropyl-myristate

Etanol absolutAbsolute ethanol

Apa purificată până laPurified water up to

100100

Exemplul 8Example 8

Component Component Cantitate (g/100g) Quantity (g / 100g) Asociere de pulberi atomizate (Cynara scolymus : Rosmarinus officinalis : Association of atomized powders (Cynara scolymus: Rosmarinus officinalis: 1 1

Hyssopus officinalis, 40:30:30%)Hyssopus officinalis, 40: 30: 30%)

Carbomer 940 Carbomer 940 1 1 Trietanolamină triethanolamine ad pH 7 at pH 7 Propilenglicol propylene 5 5 Amestec izopropil-miristat, lanolină și acid oleic Isopropyl-myristate, lanolin and oleic acid mixture 5 5

Etanol absolutAbsolute ethanol

Apa purificată până laPurified water up to

Claims (1)

Revendicăriclaims 1. Formă farmaceutică semisolidă destinată administrării locale pe piele și mucoase, caracterizată prin aceea că include între 0.1 si 5 % o asociere de extracte atomizate de Cynara scolymus, Rosmarinus officinalis sp. și Hissopus officinalis sp..1. Semi-solid pharmaceutical form for local administration on the skin and mucous membranes, characterized in that it includes between 0.1 and 5% an association of atomized extracts of Cynara scolymus, Rosmarinus officinalis sp. and Hissopus officinalis sp ..
ROA201101274A 2011-11-29 2011-11-29 Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp. RO128701A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ROA201101274A RO128701A2 (en) 2011-11-29 2011-11-29 Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ROA201101274A RO128701A2 (en) 2011-11-29 2011-11-29 Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp.

Publications (1)

Publication Number Publication Date
RO128701A2 true RO128701A2 (en) 2013-08-30

Family

ID=49030019

Family Applications (1)

Application Number Title Priority Date Filing Date
ROA201101274A RO128701A2 (en) 2011-11-29 2011-11-29 Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp.

Country Status (1)

Country Link
RO (1) RO128701A2 (en)

Similar Documents

Publication Publication Date Title
JP5798745B2 (en) Topically applied cosmetic or pharmaceutical composition
US8173145B2 (en) Formulation containing phosphate derivatives of electron transfer agents
AU2008229604A1 (en) Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
JP6352560B2 (en) External composition containing ascorbic acid and / or salt thereof
JP6231624B2 (en) Method for producing nanoliposomes for cosmetics in which oleanolic acid is collected
JP5102944B2 (en) Topical skin preparation
KR102558185B1 (en) Cosmetic composition containing pseudo-ceramide originated from botanical oil
JP2005263794A (en) Collagen synthesis acceleration composition
US6521662B2 (en) Ceramide-like compounds having antioxidant property and a method for preparation thereof, and a cosmetic composition containing the same
JP2005047910A (en) Sebum secretion-inhibiting composition
ES2804029T3 (en) Composition containing polyunsaturated fatty acid
RU2643928C2 (en) Medical and cosmetic means for external application
JP4637441B2 (en) Skin composition containing ascorbic acid
EP3283055A1 (en) Natural-substance combination containing at least one glycyrrhetinic acid and at least one guggelsterone and use thereof for cosmetic applications
RO128701A2 (en) Semi-solid pharmaceutical forms intended for topical administration, containing associations of atomized extracts of cynara scolymus, rosmarinus officinalis sp. and hyssopus officinalis sp.
JP2003063996A (en) Skin care preparation
KR101208120B1 (en) Vitamin complex, preparation methods and cosmetic composition comprising thereof
JP5856761B2 (en) External preparation for skin and method for producing the same
KR101716426B1 (en) Skin external composition for alleviating itch comprising vernixcaseosamimetic lipid complex and arctium lappa seed extracts
KR20200131795A (en) Composition for stabilizing insoluble ingredient and cosmetic composition containing the same
JP2006248953A (en) Wrinkle ameliorating agent and external composition for skin
KR101655256B1 (en) Skin external composition for alleviating itch comprising ginsenoside rg3
RU2553347C1 (en) Hair care product
JP3140513B2 (en) External pharmaceutical base and external pharmaceutical composition
JP5671211B2 (en) External preparation for skin containing hydroxycarboxylic acid derivative